147 related articles for article (PubMed ID: 23689538)
1. Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.
Dressler AC; Hudelist G; Fink-Retter A; Gschwantler-Kaulich D; Pfeiler G; Rosner M; Hengstschläger M; Singer CF
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1349-55. PubMed ID: 23689538
[TBL] [Abstract][Full Text] [Related]
2. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.
Rosner M; Hengstschläger M
J Biol Chem; 2004 Nov; 279(47):48707-15. PubMed ID: 15355997
[TBL] [Abstract][Full Text] [Related]
3. Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
Chappuis PO; Kapusta L; Bégin LR; Wong N; Brunet JS; Narod SA; Slingerland J; Foulkes WD
J Clin Oncol; 2000 Dec; 18(24):4045-52. PubMed ID: 11118465
[TBL] [Abstract][Full Text] [Related]
4. p27Kip1 localization depends on the tumor suppressor protein tuberin.
Rosner M; Freilinger A; Hanneder M; Fujita N; Lubec G; Tsuruo T; Hengstschläger M
Hum Mol Genet; 2007 Jul; 16(13):1541-56. PubMed ID: 17470459
[TBL] [Abstract][Full Text] [Related]
5. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
Miloloza A; Kubista M; Rosner M; Hengstschläger M
J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
[TBL] [Abstract][Full Text] [Related]
6. Tuberin, p27 and mTOR in different cells.
Burgstaller S; Rosner M; Lindengrün C; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Feb; 36(2):297-302. PubMed ID: 18386114
[TBL] [Abstract][Full Text] [Related]
7. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
8. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
[TBL] [Abstract][Full Text] [Related]
9. The tuberin-hamartin complex negatively regulates beta-catenin signaling activity.
Mak BC; Takemaru K; Kenerson HL; Moon RT; Yeung RS
J Biol Chem; 2003 Feb; 278(8):5947-51. PubMed ID: 12511557
[TBL] [Abstract][Full Text] [Related]
10. Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.
Aicher LD; Campbell JS; Yeung RS
J Biol Chem; 2001 Jun; 276(24):21017-21. PubMed ID: 11290735
[TBL] [Abstract][Full Text] [Related]
11. Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.
Jóźwiak S; Kwiatkowski D; Kotulska K; Larysz-Brysz M; Lewin-Kowalik J; Grajkowska W; Roszkowski M
J Child Neurol; 2004 Feb; 19(2):102-6. PubMed ID: 15072102
[TBL] [Abstract][Full Text] [Related]
12. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
13. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.
Foulkes WD; Brunet JS; Stefansson IM; Straume O; Chappuis PO; Bégin LR; Hamel N; Goffin JR; Wong N; Trudel M; Kapusta L; Porter P; Akslen LA
Cancer Res; 2004 Feb; 64(3):830-5. PubMed ID: 14871808
[TBL] [Abstract][Full Text] [Related]
14. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
Rosner M; Freilinger A; Hengstschläger M
Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
16. Akt regulates nuclear/cytoplasmic localization of tuberin.
Rosner M; Freilinger A; Hengstschläger M
Oncogene; 2007 Jan; 26(4):521-31. PubMed ID: 16862180
[TBL] [Abstract][Full Text] [Related]
17. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
18. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract][Full Text] [Related]
19. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Proteomic Profiling-derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas.
Vos S; Elias SG; van der Groep P; Smolders YH; van Gils CH; van Diest PJ
Am J Surg Pathol; 2018 Sep; 42(9):1262-1272. PubMed ID: 29979200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
